SCHEMBL22011427

SCHEMBL22011427

Ic1cc2ccc3oc4ccccc4c3c2c2c1oc1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.39
KDM4E B2RXH2 5/20 0.39
MAPT P10636 5/20 0.39
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
HSD17B10 Q99714 3/20 0.36
MAOA P21397 2/20 0.36
CYP3A4 P08684 2/20 0.36
CASP7 P55210 2/20 0.36
GLA P06280 2/20 0.36
PGAM1 P18669 1/20 0.36
CASP1 P29466 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24614774 0.90 AHR (0.40) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL26080846 0.86 MAOA (0.41) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL16412429 0.81 L3MBTL1 (0.45) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL29557435 0.81 L3MBTL1 (0.45) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL24614966 0.81 CDC14B (0.42) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL24614732 0.81 ALDH1A1 (0.41) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL24614771 0.80 NPC1 (0.36) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL24614646 0.79 HPGD (0.38) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL22011426 0.79 MAPT (0.40) HPGDKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL19108655 0.78 HPGD (0.50) HPGDKDM4EMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM HPGD 1079/4885KDM4E 3297/4885MAPT 2260/4885
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 HPGD 3659/4885KDM4E 1792/4885MAPT 4261/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 HPGD 3659/4885KDM4E 1792/4885MAPT 4261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.